This is an automatically translated article.
Fibrocystic breast is a common disease in women, especially between the ages of 30-50 and tends to disappear after menopause. To evaluate the status of benign or malignant mammary gland cysts, the doctor often appoints a paraclinical breast ultrasound test, thereby making a reasonable assessment and treatment regimen.
1. What is the Birads classification in breast ultrasound?
The Birads mammography classification is proposed by the American Society of Radiology (ACR) to standardize the diagnosis, prognosis, risk of malignancy as well as appropriate management attitude for cases of breast ultrasound. Breast ultrasound after X-ray is very necessary for women (especially in young people) to avoid missing cases of non-microcalcified lesions on solid breast background. It is also a safe method without the use of X-rays, and can be widely used in young people, children and pregnant women, especially useful because it gives better anatomical information.
To classify Birads, it is necessary to rely on benign and malignant signs suggested by the following characteristics:
1.1. Signs suggestive of benign ovality Parallel direction Clear borderline Lesions confined to the face clearly and thinly separate from adjacent healthy tissue Echogenic structure: drum echo (cystic), dense echo, variable posterior (hyperphonic) and calcification
1.2. Signs suggestive of malignancy Irregular or rounded shape Non-parallel direction Unknown borderline, spiky, angulated, or small polyarcral lesion Limit of lesion with thick echogenic margin Very poor or mixed echogenic Negative change behind dorsal shadowing Calcification Doppler ultrasound shows perfusion of metastatic lymph node with short diameter of more than 1cm, lymph node thickness greater than 3mm, loss of hilar node, extra-umbilical perfusion, polygynous border
2. Birads classification in breast ultrasound
Birads classification table includes 7 levels from 0 to 6 corresponding to ultrasound images from benign to malignant in breast ultrasound:
Birads-0: incomplete image, need further evaluation Birads -1: normal mammary organization Birads mammary gland cyst-2: benign mammary cyst (typical cyst, thickened echogenic nodule) Birads mammary gland cyst-3: lesion may be benign (adenoma) Birads-4 mammary gland cyst: suspected malignancy, requiring biopsy, which is divided into 3 levels: 4A: low suspicion, 4B: intermediate suspicion, 4C: moderate suspicion . Birads-5 mammary gland cyst: highly suggestive of malignancy, requiring immediate biopsy
Cases of Birads 1-2 breast cysts are usually benign, but patients should be monitored and screened for breast cancer annually. If diagnosed with Birads-3, the chance of malignancy is only about 2%, but it is also necessary to screen for cancer every 6 months. The cancer rate for Birads-4 is up to 23-34%, requiring a biopsy to diagnose the disease. In the case of Birads-5, the malignancy rate was up to 95%, and in Birads-6, breast cancer was confirmed.
3. Who should be screened for breast cancer?
The group of women who need annual screening for breast cancer includes:
Women over 40 years old or women with early menses (under 12 years old), late menopause (55 years old) Family history of young people with breast cancer Living and working environment often exposed to toxic substances (chemicals, radiation) Self-examination of breasts to detect lumps and abnormalities Women smoke, abuse alcohol, obesity Women taking birth control pills, hormone replacement therapy To limit breast cancer, women should also give birth early, and breastfeed regularly. Women of all ages should maintain a healthy lifestyle, exercise regularly, and maintain a healthy weight.
Breast cancer is a common cancer in women. The disease can be diagnosed through diagnostic methods and tests. Accordingly, if breast cancer can be detected early, the treatment will bring a high prognosis for the patient. Therefore, for high-risk subjects, it is necessary to have regular breast cancer screening early to improve the chances of treatment.
Currently, Vinmec International General Hospital has been implementing a breast cancer screening package for women of different ages. At Vinmec, there are all necessary medical equipment to carry out the methods of examination, diagnosis, testing, imaging, and breast cancer treatment.
Accordingly, the examination and treatment procedures at Vinmec are all performed by a team of highly qualified medical professionals who have undergone training and are granted technical certificates, which can be handled quickly and effectively. Therefore, when using Vinmec's breast cancer screening and early detection package, customers can detect cancer even when there are no symptoms.
For detailed advice on breast cancer screening packages as well as effective treatment methods at Vinmec, please come directly to Vinmec health system nationwide or register online HERE .